Dulaglutide, a modified analog of human GLP-1 covalently linked to IgG4, possesses a notably extended half-life of about 90 h, thereby expanding its therapeutic applications
doi: 10.1038/s41398-025-03499-w, 139
If you are already experienced with research peptides and comfortable managing these complexities, the compound itself is accessible
GHK-Cu (copper peptide)
This article breaks down the good, the bad, and the ugly of GLP-1 weight loss medications, with a special focus on lean muscle loss, metabolic slowdown, weight regain, and the long-term consequences that many people are not told about
Synergistic Mechanism: The GLP3 + Cagrilintide Blends dual-pathway approach activates both incretin-based metabolism (GLP-1, GIP, glucagon) and amylin-mediated satiety pathways simultaneously